• TRADE NAME: Thioplex (Amgen)
  • INDICATIONS: Breast, ovarian and bladder carcinomas
  • CLASS: Alkylating agent
  • HALF-LIFE: 109 minutes
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Aldesleukin

Please login to view the rest of this drug profile.

Page last updated 02/07/2025

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric